electroCore (ECOR) Non-Current Deffered Revenue (2017 - 2018)
electroCore's (ECOR) quarterly Non-Current Deffered Revenue came in at $245632.0 in Q4 2018, down 19.96% year-on-year from $306886.0 in Q4 2017, and down 6.42% quarter-over-quarter from $262497.0 in Q3 2018.
electroCore (ECOR) Non-Current Deffered Revenue (2017 - 2018) Analysis & Trends
electroCore's Non-Current Deffered Revenue history runs 2 years deep, the most recent figure standing at $245632.0 for Q4 2018.
- On a quarterly basis, Non-Current Deffered Revenue fell 19.96% year-over-year to $245632.0 in Q4 2018; TTM through Dec 2018 was $245632.0, a 19.96% decrease from a year earlier, with the FY2018 full-year figure at $245632.0, down 19.96% from the prior year.
- Non-Current Deffered Revenue retreated to $245632.0 in Q4 2018 per ECOR's latest filing, from $262497.0 in the prior quarter.
- Across five years, Non-Current Deffered Revenue topped out at $306886.0 in Q4 2017 and bottomed at $245632.0 in Q4 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 512.79 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | electroCore | 56,941.08 | -8.77 Mn | 8.36 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 245,632.00 |
| Sep 30, 2018 | 262,497.00 |
| Jun 30, 2018 | 279,362.00 |
| Dec 31, 2017 | 306,886.00 |